When was PhotoThera founded?

PhotoThera was founded in 1997 and raised its 1st funding round 9 years after it was founded.

Where is PhotoThera located?

PhotoThera is headquartered in Carlsbad, United States.

Is PhotoThera a funded company?

PhotoThera is a funded company, having raised a total of $80.5M across 2 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Apr 21, 2006.

When was the latest funding round of PhotoThera?

PhotoThera's latest funding was a $***** Series D round on May 01, 2009, with participation from 5 investors. Its primary sector is Neurology. In United States, the Neurology sector has seen $1.52B in funding in 2026 to date.

Where does PhotoThera rank among its competitors?

PhotoThera ranks 10th amongst 14 active competitors, of which 7 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Renerva, which secured $325K in Sep, 2025.

Who are the top competitors of PhotoThera?

PhotoThera's top competitors include AxoGen, Tulavi Nerve Therapeutics and RxFunction. Among them, Renerva secured the most recent funding round in September, 2025.

PhotoThera - 2026 Company Profile, Team, Funding & Competitors

Company Details

PhotoThera was a medical device company developing laser energy therapies for the neurology market. Currently inactive.

Key Metrics

Founded Year

1997

Location

Carlsbad, United States

Stage

Deadpooled

Total Funding

$80.5M in 2 rounds

Latest Funding Round

Series D, May 01, 2009, $*****

Investors

Warburg Pincus & 6 more

Ranked

10^th among 14 active competitors

Similar Companies

AxoGen & 16 more

View PhotoThera's full profile

PhotoThera has raised a total funding of $80.5M over 2 rounds. Its first funding round was on Apr 21, 2006. Its latest funding round was a Series D round on May 01, 2009 for $*****. 5 investors participated in its latest round. PhotoThera has 7 institutional investors.

Here is the list of recent funding rounds of PhotoThera:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2009	7717450	Series D	5248516	9873981	2827919	5022542
Apr 21, 2006	7526649	Series C	7014033	6125376	Delphi Ventures & 5 more	4097315

Access funding benchmarks and valuations. Sign up today!

View details of PhotoThera's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PhotoThera include AxoGen, Tulavi Nerve Therapeutics and RxFunction. Here is the list of Top 10 competitors of PhotoThera, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AxoGen 2002, Alachua (United States), Public	Developer of therapies for the repair of peripheral nerve injuries	$62.4M	Oberland Capital, Cardinal Partners & 9 others	61/100
2nd	Tulavi Nerve Therapeutics 2020, Mountain View (United States), Series A	Developer of the therapeutic device to treat neurally mediated diseases	$11.5M	Ascension Ventures, Delos Capital Partners ... & 1 others	56/100
3rd	RxFunction 2010, Minneapolis (United States), Series B	Provider of wearable prosthesis for people with sensory peripheral neuropathy	$39.9M	HHS & 1 others	52/100
4th	BioCircuit 2016, Atlanta (United States), Series B	Developer of non-invasive electrophysiology devices to monitor peripheral nerves	$13.6M	Masters Capital Management, NIH & 4 others	42/100
5th	Epineuron 2016, Hamilton (Canada), Seed	Provider of medical devices for peripheral nerve injury treatment	-	Ontario Centre of Innovation, Ontario Brain Institute ... & 4 others	38/100
6th	Renerva 2017, Pittsburgh (United States), Seed	Surgical solutions advancing nerve recovery, restoring hope after nerve injury	$1.28M	Defense.gov, NIH & 3 others	37/100
7th	Micro Leads 2014, Boston (United States), Seed	Precision neuromodulation therapies using minimally-invasive, high-resolution devices for nervous system interfaces	-	Massachusetts Life Sciences Center, GSK & 4 others	34/100
8th	Monarch Bioimplants 2016, Root (Switzerland), Series B	Developer of bioimplant for peripheral nerve repair	$24.9M	Global Emerging Markets, FastTrack Ventures	34/100
9th	Newrotex 2019, Oxford (United Kingdom), Funding Raised	Provider of silk-based solutions for the treatment of peripheral nerve injuries	-	EIC Fund, MedTech Innovator	33/100
10th	PhotoThera 1997, Carlsbad (United States), Deadpooled	Laser therapies	$80.5M	Warburg Pincus, The Vertical Group & 5 others	31/100